Eric M. Welch, DMP, MS

Direct-to-treatment (DTT) streamlines simulation, planning, QA and treatment into same-day, risk-managed pathways that start from diagnostic imaging or treatment-unit imaging. Clinical and physics evidence now supports multiple entry points: diagnostic-CT bas...

Proton therapy offers distinct dosimetric advantages for reirradiation (reRT) due to its finite range and Bragg peak, allowing potential tumor dose escalation with reduced normal tissue exposure compared to photon-based reRT. However, these benefits come with...

Clinical evidence generally suggests proton therapy can reduce treatment-related toxicity, especially in tumors near critical structures such as the brain, spinal cord, heart. This benefit is well established in pediatric cancers, where reducing radiation exp...

This educational session will examine necessity and evolving role of patient-specific quality assurance (PSQA) methods for inversely-optimized plans that improve clinical efficiency and ensure patient safety when an immediate turn around is required for treat...

“I wonder how other centers are addressing this issue” – Is a question that comes up frequently in particle therapy, which is a challenging and constantly evolving field. The Working Group on Particle Therapy Delivery and Practice (WGPDP) was recently formed...

This session will present three of the most recently published or approved for publication Task Group or Scientific Reports under the Therapy Physics Committee. These report have not been presented before to the membership. These documents have already been r...

Spatially Fractionated Radiation Therapy (SFRT) has generated significant interest as a promising approach for treating bulky and resistant tumors. Its effectiveness stems not only from the underlying physics and dosimetry but also from advances in modern rad...